A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity

• Главные авторы: Ute Klinkhardt (Автор), Mirjam Schunk (Автор), John Ervin (Автор), Christoph Schindler (Автор), Danny Sugimoto (Автор), Bruce Rankin (Автор), Ralf Amann (Автор), Martina Monti (Автор), Anna Kutschenko (Автор), Carsten Schumacher (Автор), Kristina Huber (Автор), Andreas Zeder (Автор), Nelli Heikkila (Автор), Arnaud M. Didierlaurent (Автор), Sylvia E. Schwarz (Автор), Madiha Derouazi (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Next-generation COVID-19 vaccines are being developed to expand the breadth of coverage against existing and future variants and to extend the duration of protection. Prime-2-CoV_Beta is an orf virus (ORFV) based multi-antigen COVID-19 vaccine that co-expresses Spike (S) and Nucleocapsid (N) antigen...